Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
10684 | 1042 | 45.0 | 72% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
103 | 3 | O GLCNACYLATION//O GLCNAC TRANSFERASE//O GLCNACASE | 73436 |
321 | 2 | N GLYCAN//GLYCOBIOLOGY//GLYCOPROTEOMICS | 18230 |
10684 | 1 | GLYCOPEPTIDES//TUMOR VACCINOL//ANTITUMOR VACCINES | 1042 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | GLYCOPEPTIDES | authKW | 593005 | 15% | 13% | 156 |
2 | TUMOR VACCINOL | address | 258661 | 2% | 55% | 16 |
3 | ANTITUMOR VACCINES | authKW | 221597 | 1% | 69% | 11 |
4 | CARL S MARVEL S | address | 170486 | 1% | 73% | 8 |
5 | SOLID PHASE GLYCOPEPTIDE SYNTHESIS | authKW | 130527 | 1% | 64% | 7 |
6 | TUMOR ANTIGEN IMMUNOCHEM | address | 93768 | 0% | 80% | 4 |
7 | CARBOHYDRATE BASED ANTITUMOR VACCINES | authKW | 87909 | 0% | 100% | 3 |
8 | GLYCOPEPTIDE ANTIGENS | authKW | 87909 | 0% | 100% | 3 |
9 | TUMOR ASSOCIATED CARBOHYDRATE ANTIGEN | authKW | 84453 | 1% | 41% | 7 |
10 | INVEST SINTESIS QUIM | address | 77358 | 1% | 20% | 13 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Organic | 6379 | 36% | 0% | 372 |
2 | Chemistry, Multidisciplinary | 1873 | 29% | 0% | 301 |
3 | Biochemistry & Molecular Biology | 1479 | 33% | 0% | 349 |
4 | Chemistry, Applied | 1117 | 10% | 0% | 108 |
5 | Chemistry, Medicinal | 375 | 6% | 0% | 66 |
6 | Biochemical Research Methods | 40 | 3% | 0% | 32 |
7 | Biophysics | 32 | 3% | 0% | 33 |
8 | Oncology | 31 | 5% | 0% | 53 |
9 | Immunology | 29 | 5% | 0% | 47 |
10 | Spectroscopy | 0 | 1% | 0% | 9 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TUMOR VACCINOL | 258661 | 2% | 55% | 16 |
2 | CARL S MARVEL S | 170486 | 1% | 73% | 8 |
3 | TUMOR ANTIGEN IMMUNOCHEM | 93768 | 0% | 80% | 4 |
4 | INVEST SINTESIS QUIM | 77358 | 1% | 20% | 13 |
5 | SOLID TUMOR IMMUNOL | 65930 | 0% | 75% | 3 |
6 | PREPARAT SYNTH CORE IL | 61042 | 0% | 42% | 5 |
7 | GENITOURINARY SOLID TUMOR ONCOL | 58606 | 0% | 100% | 2 |
8 | POLE INTEGRE RECH CLIN | 58606 | 0% | 100% | 2 |
9 | ORGAN SYNTH CORE | 46880 | 0% | 40% | 4 |
10 | PL BIOCHEM BIOTECHNOL | 42617 | 0% | 36% | 4 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CARBOHYDRATE RESEARCH | 15560 | 8% | 1% | 85 |
2 | INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH | 7872 | 2% | 1% | 26 |
3 | MAGNETIC RESONANCE IN BIOLOGY | 5859 | 0% | 20% | 1 |
4 | ADVANCES IN CARBOHYDRATE CHEMISTRY AND BIOCHEMISTRY | 4974 | 0% | 3% | 5 |
5 | GLYCOCONJUGATE JOURNAL | 3792 | 2% | 1% | 16 |
6 | LIEBIGS ANNALEN DER CHEMIE | 3265 | 2% | 1% | 19 |
7 | JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1 | 2951 | 3% | 0% | 34 |
8 | ANGEWANDTE CHEMIE-INTERNATIONAL EDITION | 2833 | 6% | 0% | 62 |
9 | JOURNAL OF PEPTIDE RESEARCH | 2573 | 1% | 1% | 9 |
10 | JOURNAL OF CARBOHYDRATE CHEMISTRY | 2389 | 1% | 1% | 13 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ZANG, F , LIU, G , (2006) SOLID-PHASE SYNTHESIS OF GLYCOPEPTIDES.PROGRESS IN CHEMISTRY. VOL. 18. ISSUE 5. P. 579-600 | 67 | 74% | 0 |
2 | FENG, DY , SHAIKH, AS , WANG, FS , (2016) RECENT ADVANCE IN TUMOR-ASSOCIATED CARBOHYDRATE ANTIGENS (TACAS)-BASED ANTITUMOR VACCINES.ACS CHEMICAL BIOLOGY. VOL. 11. ISSUE 4. P. 850 -863 | 54 | 46% | 5 |
3 | WILSON, RM , DANISHEFSKY, SJ , (2013) A VISION FOR VACCINES BUILT FROM FULLY SYNTHETIC TUMOR-ASSOCIATED ANTIGENS: FROM THE LABORATORY TO THE CLINIC.JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. VOL. 135. ISSUE 39. P. 14462 -14472 | 42 | 65% | 42 |
4 | HERZNER, H , REIPEN, T , SCHULTZ, M , KUNZ, H , (2000) SYNTHESIS OF GLYCOPEPTIDES CONTAINING CARBOHYDRATE AND PEPTIDE RECOGNITION MOTIFS.CHEMICAL REVIEWS. VOL. 100. ISSUE 12. P. 4495 -4537 | 86 | 40% | 224 |
5 | GAIDZIK, N , WESTERLIND, U , KUNZ, H , (2013) THE DEVELOPMENT OF SYNTHETIC ANTITUMOUR VACCINES FROM MUCIN GLYCOPEPTIDE ANTIGENS.CHEMICAL SOCIETY REVIEWS. VOL. 42. ISSUE 10. P. 4421 -4442 | 41 | 59% | 56 |
6 | SEITZ, O , (2000) GLYCOPEPTIDE SYNTHESIS AND THE EFFECTS OF GLYCOSYLATION ON PROTEIN STRUCTURE AND ACTIVITY.CHEMBIOCHEM. VOL. 1. ISSUE 4. P. 215 -246 | 95 | 43% | 17 |
7 | KIHLBERG, J , ELOFSSON, M , (1997) SOLID-PHASE SYNTHESIS OF GLYCOPEPTIDES: IMMUNOLOGICAL STUDIES WITH T CELL STIMULATING GLYCOPEPTIDES.CURRENT MEDICINAL CHEMISTRY. VOL. 4. ISSUE 2. P. 85-116 | 91 | 50% | 0 |
8 | ARSEQUELL, G , VALENCIA, G , (1997) O-GLYCOSYL ALPHA-AMINO ACIDS AS BUILDING BLOCKS FOR GLYCOPEPTIDE SYNTHESIS.TETRAHEDRON-ASYMMETRY. VOL. 8. ISSUE 17. P. 2839-2876 | 91 | 43% | 78 |
9 | HOJO, H , NAKAHARA, Y , (2000) RECENT PROGRESS IN THE SOLID-PHASE SYNTHESIS OF GLYCOPEPTIDE.CURRENT PROTEIN & PEPTIDE SCIENCE. VOL. 1. ISSUE 1. P. 23-48 | 48 | 74% | 24 |
10 | HEVEY, R , LING, CC , (2012) RECENT ADVANCES IN DEVELOPING SYNTHETIC CARBOHYDRATE-BASED VACCINES FOR CANCER IMMUNOTHERAPIES.FUTURE MEDICINAL CHEMISTRY. VOL. 4. ISSUE 4. P. 545 -584 | 83 | 27% | 19 |
Classes with closest relation at Level 1 |